Verily Impact Investors
Verily is an Alphabet precision health company that helps pharma and consumer health companies develop safe, effective treatments faster and enable patients, providers and payors to make better care decisions
Investors
Total Funding:
3500000000.0
Acquisitions Number:
Made Acquisitions
Headquarters:
South San Francisco, California, United States
Funding Status:
Private Equity
Employee Number:
1001-5000
Estimated Revenue:
$100M to $500M
Last Funding Type:
Secondary Market
Number Of Exists:
4
Last Funding Date:
2022-09-28
Investors Number:
6
Founded Date:
2015-01-01
Industry:
End-to-End Drug Development